
Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Eledon Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
Eledon Pharmaceuticals, Inc. has approximately 11-50 employees employees.
Eledon Pharmaceuticals, Inc. is based in Irvine, California, United States.
Yes. Eledon Pharmaceuticals, Inc. is a publicly traded company.
You can reach Eledon Pharmaceuticals, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com